Hellerstedt Beth A, Pienta Kenneth J
Division of Hematology and Oncology, University of Michigan Medical Center, Ann Arbor, USA.
CA Cancer J Clin. 2002 May-Jun;52(3):154-79. doi: 10.3322/canjclin.52.3.154.
Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.
雄激素剥夺疗法仍然是前列腺癌男性患者的主要治疗方法。激素疗法的新用途,包括在辅助和新辅助治疗中的应用,正在进行评估。对治疗副作用的预防促使了替代方案和治疗方法的发展。